| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Folic Acid | 35 | 2003 | 123 | 2.010 |
Why?
|
| Escherichia coli | 4 | 2017 | 368 | 1.430 |
Why?
|
| Microscopy | 2 | 2019 | 64 | 1.260 |
Why?
|
| Leucovorin | 16 | 2001 | 35 | 1.160 |
Why?
|
| Tetrahydrofolates | 21 | 1998 | 28 | 1.120 |
Why?
|
| DNA, Bacterial | 2 | 2014 | 150 | 0.900 |
Why?
|
| Transcription Factors | 3 | 2021 | 753 | 0.780 |
Why?
|
| Thymidylate Synthase | 20 | 2001 | 42 | 0.760 |
Why?
|
| Spectrometry, Fluorescence | 3 | 2020 | 112 | 0.720 |
Why?
|
| Folic Acid Antagonists | 12 | 2002 | 20 | 0.700 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 18 | 0.600 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 271 | 0.590 |
Why?
|
| Lac Repressors | 2 | 2014 | 4 | 0.590 |
Why?
|
| Methotrexate | 19 | 2002 | 91 | 0.590 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 1293 | 0.580 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2017 | 46 | 0.560 |
Why?
|
| Repressor Proteins | 2 | 2014 | 183 | 0.530 |
Why?
|
| Nucleosomes | 3 | 2021 | 25 | 0.510 |
Why?
|
| Promoter Regions, Genetic | 4 | 2021 | 615 | 0.470 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2013 | 5 | 0.470 |
Why?
|
| Folic Acid Deficiency | 4 | 1999 | 16 | 0.450 |
Why?
|
| Fluorouracil | 7 | 2001 | 130 | 0.440 |
Why?
|
| Pteroylpolyglutamic Acids | 11 | 1999 | 11 | 0.420 |
Why?
|
| Antimetabolites, Antineoplastic | 4 | 2001 | 77 | 0.420 |
Why?
|
| Methyltransferases | 8 | 1983 | 19 | 0.390 |
Why?
|
| Liver | 14 | 1997 | 1118 | 0.380 |
Why?
|
| Cell Nucleus | 3 | 2021 | 305 | 0.370 |
Why?
|
| Chromatin | 2 | 2021 | 76 | 0.350 |
Why?
|
| Peptide Synthases | 9 | 1999 | 13 | 0.340 |
Why?
|
| Fluorodeoxyuridylate | 7 | 1991 | 7 | 0.310 |
Why?
|
| Leukemia L1210 | 5 | 1994 | 14 | 0.290 |
Why?
|
| Genes, Reporter | 3 | 2020 | 191 | 0.270 |
Why?
|
| Tumor Cells, Cultured | 18 | 2003 | 852 | 0.270 |
Why?
|
| Deoxyuracil Nucleotides | 5 | 1986 | 9 | 0.270 |
Why?
|
| DNA | 4 | 2019 | 597 | 0.260 |
Why?
|
| Carbon-Nitrogen Ligases | 2 | 1997 | 2 | 0.240 |
Why?
|
| Liver Neoplasms, Experimental | 7 | 1991 | 38 | 0.240 |
Why?
|
| Lac Operon | 2 | 2014 | 54 | 0.240 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2021 | 173 | 0.220 |
Why?
|
| Ovarian Neoplasms | 4 | 1995 | 267 | 0.220 |
Why?
|
| Green Fluorescent Proteins | 2 | 2020 | 200 | 0.210 |
Why?
|
| Neoplasms, Experimental | 3 | 1999 | 118 | 0.210 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 1997 | 468 | 0.200 |
Why?
|
| Quinazolines | 5 | 2001 | 70 | 0.200 |
Why?
|
| Genome, Fungal | 1 | 2021 | 6 | 0.190 |
Why?
|
| Kinetics | 21 | 1998 | 1047 | 0.190 |
Why?
|
| Transcription, Genetic | 2 | 2021 | 562 | 0.190 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2020 | 2 | 0.190 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 68 | 0.190 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2020 | 24 | 0.180 |
Why?
|
| Huntingtin Protein | 1 | 2020 | 5 | 0.180 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2020 | 3 | 0.180 |
Why?
|
| Ribosomes | 1 | 2020 | 23 | 0.180 |
Why?
|
| Protein Aggregates | 1 | 2020 | 11 | 0.180 |
Why?
|
| Exons | 1 | 2020 | 122 | 0.180 |
Why?
|
| Protein Multimerization | 1 | 2020 | 71 | 0.180 |
Why?
|
| Membrane Transport Proteins | 4 | 2003 | 81 | 0.180 |
Why?
|
| Mice | 24 | 2001 | 8474 | 0.180 |
Why?
|
| Biophysical Phenomena | 1 | 2019 | 25 | 0.170 |
Why?
|
| Animals | 35 | 2001 | 20881 | 0.160 |
Why?
|
| Leukemia, T-Cell | 1 | 1998 | 21 | 0.160 |
Why?
|
| Base Sequence | 6 | 2021 | 1015 | 0.150 |
Why?
|
| Genome | 1 | 2018 | 54 | 0.150 |
Why?
|
| Carrier Proteins | 5 | 2002 | 597 | 0.150 |
Why?
|
| Drug Synergism | 6 | 2001 | 260 | 0.140 |
Why?
|
| Carcinoma, Krebs 2 | 3 | 1986 | 3 | 0.140 |
Why?
|
| RNA, Messenger | 2 | 2020 | 1664 | 0.140 |
Why?
|
| Binding Sites | 5 | 2014 | 631 | 0.140 |
Why?
|
| Urate Oxidase | 4 | 1980 | 5 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 7 | 1995 | 272 | 0.130 |
Why?
|
| Time Factors | 7 | 2020 | 4655 | 0.130 |
Why?
|
| Operator Regions, Genetic | 1 | 2014 | 5 | 0.120 |
Why?
|
| DNA, Superhelical | 1 | 2014 | 8 | 0.120 |
Why?
|
| Erythrocytes | 2 | 1994 | 137 | 0.120 |
Why?
|
| Thermodynamics | 2 | 2013 | 162 | 0.120 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2014 | 50 | 0.120 |
Why?
|
| Thymidine Monophosphate | 3 | 1990 | 5 | 0.120 |
Why?
|
| Nucleic Acid Conformation | 1 | 2014 | 92 | 0.120 |
Why?
|
| Mice, Inbred C3H | 4 | 2001 | 134 | 0.120 |
Why?
|
| Monte Carlo Method | 1 | 2014 | 124 | 0.120 |
Why?
|
| Stress, Mechanical | 1 | 2014 | 208 | 0.120 |
Why?
|
| Peritoneum | 1 | 1994 | 27 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 195 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2013 | 63 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 62 | 0.110 |
Why?
|
| gamma-Glutamyl Hydrolase | 5 | 1995 | 6 | 0.110 |
Why?
|
| Chromosomes, Bacterial | 1 | 2013 | 7 | 0.110 |
Why?
|
| Escherichia coli Proteins | 1 | 2013 | 65 | 0.110 |
Why?
|
| Viral Proteins | 1 | 2014 | 150 | 0.110 |
Why?
|
| Salmonella typhimurium | 1 | 2013 | 15 | 0.110 |
Why?
|
| Cell Line | 8 | 1995 | 1752 | 0.110 |
Why?
|
| Intestinal Mucosa | 1 | 1994 | 219 | 0.110 |
Why?
|
| Tritium | 7 | 1999 | 101 | 0.110 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 357 | 0.110 |
Why?
|
| Prodrugs | 1 | 1993 | 54 | 0.100 |
Why?
|
| Thymine Nucleotides | 2 | 1990 | 6 | 0.100 |
Why?
|
| Humans | 27 | 2020 | 68618 | 0.100 |
Why?
|
| Antineoplastic Agents | 3 | 2000 | 1070 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2014 | 448 | 0.090 |
Why?
|
| Diet | 4 | 2001 | 514 | 0.090 |
Why?
|
| Formyltetrahydrofolates | 2 | 1991 | 2 | 0.090 |
Why?
|
| Models, Theoretical | 1 | 2013 | 384 | 0.090 |
Why?
|
| DNA, Neoplasm | 2 | 1995 | 95 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 1998 | 492 | 0.090 |
Why?
|
| Administration, Oral | 4 | 1999 | 411 | 0.090 |
Why?
|
| Peptides | 3 | 2020 | 455 | 0.090 |
Why?
|
| Enzyme Inhibitors | 4 | 2001 | 659 | 0.090 |
Why?
|
| Polyglutamic Acid | 4 | 1994 | 4 | 0.090 |
Why?
|
| Carboxypeptidases | 3 | 1986 | 8 | 0.090 |
Why?
|
| Mice, Inbred ICR | 2 | 1986 | 44 | 0.090 |
Why?
|
| Apoptosis | 2 | 2005 | 1641 | 0.080 |
Why?
|
| Thymidine | 3 | 2001 | 32 | 0.080 |
Why?
|
| Gene Expression | 2 | 2005 | 770 | 0.080 |
Why?
|
| Copper | 2 | 1988 | 149 | 0.080 |
Why?
|
| Glutamates | 5 | 2001 | 41 | 0.080 |
Why?
|
| DNA Primers | 3 | 2013 | 302 | 0.080 |
Why?
|
| Cell Division | 8 | 2003 | 541 | 0.080 |
Why?
|
| Acrylic Resins | 1 | 1988 | 48 | 0.080 |
Why?
|
| Algorithms | 1 | 2013 | 1196 | 0.080 |
Why?
|
| Hydrogen Peroxide | 1 | 1988 | 168 | 0.070 |
Why?
|
| Protein Binding | 6 | 2014 | 1027 | 0.070 |
Why?
|
| Cell Cycle | 2 | 1994 | 312 | 0.070 |
Why?
|
| Injections, Intravenous | 3 | 1999 | 215 | 0.070 |
Why?
|
| Proteins | 2 | 1999 | 474 | 0.070 |
Why?
|
| Cisplatin | 1 | 1986 | 192 | 0.070 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2005 | 39 | 0.070 |
Why?
|
| Carcinoma | 1 | 1986 | 215 | 0.060 |
Why?
|
| Drug Resistance | 5 | 1999 | 223 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2002 | 332 | 0.060 |
Why?
|
| Ligases | 2 | 1997 | 6 | 0.060 |
Why?
|
| Leukemia | 2 | 2002 | 117 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2005 | 231 | 0.060 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 1447 | 0.060 |
Why?
|
| Membrane Proteins | 2 | 1998 | 617 | 0.060 |
Why?
|
| Stereoisomerism | 3 | 1995 | 169 | 0.050 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 2003 | 24 | 0.050 |
Why?
|
| Receptors, Cell Surface | 2 | 1995 | 248 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 2014 | 420 | 0.050 |
Why?
|
| Models, Biological | 2 | 2020 | 981 | 0.050 |
Why?
|
| Lysosomes | 2 | 1999 | 136 | 0.050 |
Why?
|
| Biological Transport | 4 | 1998 | 210 | 0.050 |
Why?
|
| Biotransformation | 2 | 1993 | 69 | 0.050 |
Why?
|
| Pyrimidines | 2 | 2000 | 178 | 0.050 |
Why?
|
| Muscles | 1 | 1982 | 158 | 0.050 |
Why?
|
| Kidney | 3 | 1986 | 945 | 0.050 |
Why?
|
| Homeostasis | 1 | 2003 | 291 | 0.050 |
Why?
|
| Guanine | 1 | 2001 | 21 | 0.050 |
Why?
|
| Histone Code | 1 | 2020 | 5 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2020 | 16 | 0.050 |
Why?
|
| Inclusion Bodies | 1 | 2020 | 10 | 0.050 |
Why?
|
| Potassium Cyanide | 1 | 1980 | 8 | 0.050 |
Why?
|
| Cyanides | 1 | 1980 | 15 | 0.050 |
Why?
|
| Floxuridine | 1 | 1980 | 20 | 0.050 |
Why?
|
| Female | 10 | 2001 | 38074 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 109 | 0.040 |
Why?
|
| DNA Repair | 1 | 2020 | 127 | 0.040 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 2 | 2000 | 2 | 0.040 |
Why?
|
| Antidotes | 1 | 1999 | 21 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 1994 | 160 | 0.040 |
Why?
|
| Pyrimethamine | 3 | 1999 | 3 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 326 | 0.040 |
Why?
|
| Transcription Initiation Site | 1 | 2019 | 11 | 0.040 |
Why?
|
| Chromosomes | 1 | 2019 | 17 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 23 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2005 | 756 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2020 | 376 | 0.040 |
Why?
|
| Species Specificity | 3 | 1986 | 303 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1991 | 765 | 0.040 |
Why?
|
| DNA, Antisense | 1 | 1998 | 9 | 0.040 |
Why?
|
| Glioma | 1 | 1999 | 140 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 2018 | 12 | 0.040 |
Why?
|
| Cells, Cultured | 5 | 1999 | 2673 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2020 | 431 | 0.040 |
Why?
|
| Microscopy, Electron | 1 | 2018 | 351 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2019 | 123 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 1999 | 291 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2005 | 1200 | 0.040 |
Why?
|
| Trimetrexate | 3 | 1998 | 4 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 190 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2001 | 1745 | 0.040 |
Why?
|
| Mutation | 1 | 2002 | 1213 | 0.040 |
Why?
|
| Infusions, Intravenous | 2 | 2000 | 334 | 0.040 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1998 | 282 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1994 | 70 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 1173 | 0.040 |
Why?
|
| Down-Regulation | 1 | 1998 | 447 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 1997 | 114 | 0.030 |
Why?
|
| Reduced Folate Carrier Protein | 3 | 2002 | 6 | 0.030 |
Why?
|
| Reference Values | 2 | 1994 | 579 | 0.030 |
Why?
|
| Acyltransferases | 1 | 1995 | 40 | 0.030 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1995 | 40 | 0.030 |
Why?
|
| Sigma Factor | 1 | 2014 | 5 | 0.030 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2014 | 16 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2014 | 34 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2014 | 60 | 0.030 |
Why?
|
| Genistein | 1 | 1994 | 26 | 0.030 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 1994 | 11 | 0.030 |
Why?
|
| Isoflavones | 1 | 1994 | 31 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 1994 | 18 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 159 | 0.030 |
Why?
|
| Chemical Phenomena | 4 | 1982 | 62 | 0.030 |
Why?
|
| Chemistry | 4 | 1982 | 45 | 0.030 |
Why?
|
| Epitopes | 1 | 2014 | 146 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 2 | 1986 | 14 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 1997 | 475 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2014 | 161 | 0.030 |
Why?
|
| Paclitaxel | 1 | 1994 | 140 | 0.030 |
Why?
|
| Rats | 4 | 1989 | 5300 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 322 | 0.030 |
Why?
|
| Epithelium | 1 | 1994 | 172 | 0.030 |
Why?
|
| Plasmids | 1 | 2014 | 258 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 284 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 2013 | 14 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2013 | 41 | 0.030 |
Why?
|
| Methods | 2 | 1991 | 156 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2014 | 546 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1083 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2013 | 312 | 0.030 |
Why?
|
| Methionine | 2 | 1989 | 36 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 1999 | 2550 | 0.030 |
Why?
|
| Xanthine Oxidase | 1 | 1971 | 15 | 0.020 |
Why?
|
| Brain | 1 | 1982 | 2176 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1991 | 163 | 0.020 |
Why?
|
| Leukocytes | 1 | 1991 | 99 | 0.020 |
Why?
|
| Thymidine Kinase | 2 | 2001 | 18 | 0.020 |
Why?
|
| Rabbits | 1 | 1991 | 509 | 0.020 |
Why?
|
| Aspergillus flavus | 2 | 1980 | 3 | 0.020 |
Why?
|
| Xanthine | 2 | 1980 | 14 | 0.020 |
Why?
|
| Random Allocation | 1 | 1991 | 442 | 0.020 |
Why?
|
| Xanthines | 2 | 1980 | 17 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 1991 | 334 | 0.020 |
Why?
|
| Iron | 2 | 1982 | 197 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 1989 | 120 | 0.020 |
Why?
|
| Hypoxanthines | 1 | 1989 | 6 | 0.020 |
Why?
|
| Hypoxanthine | 1 | 1989 | 8 | 0.020 |
Why?
|
| Neoplasms | 1 | 2000 | 1667 | 0.020 |
Why?
|
| Swine | 2 | 1985 | 672 | 0.020 |
Why?
|
| Copper Sulfate | 1 | 1988 | 4 | 0.020 |
Why?
|
| Scintillation Counting | 1 | 1988 | 5 | 0.020 |
Why?
|
| Male | 6 | 2000 | 37321 | 0.020 |
Why?
|
| Phosphoribosylglycinamide Formyltransferase | 2 | 2000 | 2 | 0.020 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 2 | 1995 | 9 | 0.020 |
Why?
|
| Solubility | 1 | 1988 | 134 | 0.020 |
Why?
|
| Substrate Specificity | 3 | 1986 | 234 | 0.020 |
Why?
|
| Chromatography, Gel | 2 | 1995 | 79 | 0.020 |
Why?
|
| Adult | 3 | 2000 | 21403 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 1993 | 561 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2001 | 532 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1991 | 597 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 1987 | 39 | 0.020 |
Why?
|
| Cell Survival | 1 | 1989 | 901 | 0.020 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 65 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 1986 | 282 | 0.020 |
Why?
|
| Serine | 1 | 2005 | 99 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 100 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2005 | 204 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1986 | 381 | 0.020 |
Why?
|
| Sodium Dodecyl Sulfate | 2 | 1986 | 24 | 0.020 |
Why?
|
| Protein Transport | 1 | 2005 | 280 | 0.020 |
Why?
|
| RNA Interference | 1 | 2005 | 266 | 0.020 |
Why?
|
| Folate Receptors, GPI-Anchored | 2 | 1995 | 6 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2005 | 314 | 0.010 |
Why?
|
| Colonic Neoplasms | 2 | 2001 | 299 | 0.010 |
Why?
|
| Liposomes | 1 | 1983 | 107 | 0.010 |
Why?
|
| Computers | 2 | 1974 | 63 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 5 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 1989 | 2791 | 0.010 |
Why?
|
| Ferritins | 1 | 1982 | 49 | 0.010 |
Why?
|
| Iron Chelating Agents | 1 | 1982 | 31 | 0.010 |
Why?
|
| Fluorometry | 1 | 1981 | 7 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1982 | 69 | 0.010 |
Why?
|
| Pemetrexed | 1 | 2001 | 1 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1981 | 128 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1981 | 73 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 710 | 0.010 |
Why?
|
| Thiophenes | 1 | 2001 | 76 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 1851 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2000 | 48 | 0.010 |
Why?
|
| Calorimetry | 1 | 1980 | 21 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 954 | 0.010 |
Why?
|
| Centrifugation | 1 | 1980 | 16 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1980 | 27 | 0.010 |
Why?
|
| United Kingdom | 1 | 2000 | 152 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 173 | 0.010 |
Why?
|
| CHO Cells | 1 | 1999 | 161 | 0.010 |
Why?
|
| Cricetinae | 1 | 1999 | 262 | 0.010 |
Why?
|
| Affinity Labels | 1 | 1998 | 66 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1998 | 189 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1980 | 618 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 737 | 0.010 |
Why?
|
| Rats, Inbred Lew | 2 | 1989 | 150 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 1974 | 79 | 0.010 |
Why?
|
| Glucose | 1 | 1999 | 307 | 0.010 |
Why?
|
| Uric Acid | 2 | 1974 | 37 | 0.010 |
Why?
|
| S-Adenosylmethionine | 1 | 1997 | 9 | 0.010 |
Why?
|
| Adenosine | 1 | 1997 | 165 | 0.010 |
Why?
|
| Formate-Tetrahydrofolate Ligase | 1 | 1995 | 1 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 1995 | 1 | 0.010 |
Why?
|
| 5,10-Methylenetetrahydrofolate Reductase (FADH2) | 1 | 1995 | 1 | 0.010 |
Why?
|
| Phosphoribosylaminoimidazolecarboxamide Formyltransferase | 1 | 1995 | 1 | 0.010 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 1995 | 2 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 1995 | 17 | 0.010 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 1995 | 12 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1995 | 294 | 0.010 |
Why?
|
| Clone Cells | 1 | 1995 | 67 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1995 | 251 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 1974 | 54 | 0.010 |
Why?
|
| Mathematics | 1 | 1974 | 83 | 0.010 |
Why?
|
| Oxidation-Reduction | 2 | 1989 | 567 | 0.010 |
Why?
|
| Oxidoreductases | 1 | 1995 | 117 | 0.010 |
Why?
|
| Free Radicals | 1 | 1974 | 65 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1974 | 358 | 0.010 |
Why?
|
| Electrodes | 1 | 1974 | 147 | 0.010 |
Why?
|
| Actins | 1 | 1995 | 249 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1994 | 268 | 0.010 |
Why?
|
| Oxygen | 1 | 1974 | 386 | 0.010 |
Why?
|
| Xanthopterin | 1 | 1971 | 1 | 0.010 |
Why?
|
| Pteridines | 1 | 1971 | 5 | 0.010 |
Why?
|
| Deoxyuridine | 1 | 1991 | 8 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1991 | 34 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1991 | 165 | 0.010 |
Why?
|
| Chickens | 1 | 1971 | 232 | 0.010 |
Why?
|
| Glycine | 1 | 1991 | 89 | 0.010 |
Why?
|
| Models, Chemical | 1 | 1971 | 155 | 0.010 |
Why?
|
| Hydroxylation | 1 | 1989 | 41 | 0.010 |
Why?
|
| United States | 1 | 2000 | 7367 | 0.000 |
Why?
|
| Sarcoma 180 | 1 | 1986 | 1 | 0.000 |
Why?
|
| Micelles | 1 | 1986 | 43 | 0.000 |
Why?
|
| Mice, Inbred CBA | 1 | 1986 | 107 | 0.000 |
Why?
|
| Glutamic Acid | 1 | 1989 | 332 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1986 | 89 | 0.000 |
Why?
|
| Aged | 1 | 2000 | 14862 | 0.000 |
Why?
|
| Child | 1 | 1994 | 6405 | 0.000 |
Why?
|
| Apoferritins | 1 | 1982 | 6 | 0.000 |
Why?
|
| Middle Aged | 1 | 2000 | 21147 | 0.000 |
Why?
|
| Temperature | 1 | 1982 | 341 | 0.000 |
Why?
|
| Polymers | 1 | 1982 | 244 | 0.000 |
Why?
|
| Allantoin | 1 | 1972 | 2 | 0.000 |
Why?
|
| Borates | 1 | 1972 | 3 | 0.000 |
Why?
|
| Buffers | 1 | 1972 | 31 | 0.000 |
Why?
|
| Half-Life | 1 | 1972 | 96 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1972 | 134 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1972 | 219 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1972 | 258 | 0.000 |
Why?
|